EXOZ · Insider Trading
eXoZymes Inc. Common Stock
Every open-market purchase and sale reported by EXOZ officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-26 | Damien Alan Perriman | Chief Commercial Officer | MIXED | +193 | −$19.43K |
| 2026-10-21 | Tyler Paz Korman | Chief Scientific Officer | — | — | — |
| 2026-10-19 | James Joseph Lalonde | Director | A | +10,000 deriv. | — |
| 2026-10-19 | Lon E Bell | Director | A | +10,000 deriv. | — |
| 2026-10-19 | Anthony Digiandomenico | Director | A | — | — |
| 2026-10-19 | Edgardo Javier Rayo | Director | A | — | — |
| 2026-10-19 | Christopher A Marlett | Director | A | — | — |
| 2026-10-19 | James Ulrich Bowie | Director | A | — | — |
| 2026-09-17 | Fouad Nawaz | Vice President- Finance | A | — | — |
| 2026-09-02 | Michael Heltzen | Chief Executive Officer | MIXED | +9,696 | +$62.99K |
| 2026-08-25 | Tyler Paz Korman | Chief Scientific Officer | M | +32,964 | — |
| 2026-08-25 | Damien Alan Perriman | Chief Commercial Officer | M | +19,612 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Christopher A Marlett | Director | 3,808,476 | $14.28M |
| Anthony Digiandomenico | Director | 3,808,476 | $14.28M |
| Tyler Paz Korman | Chief Scientific Officer | 729,123 | $2.73M |
| James Ulrich Bowie | Director | 577,910 | $2.17M |
| Edgardo Javier Rayo | Director | 77,909 | $292.16K |
| Damien Alan Perriman | Chief Commercial Officer | 28,499 | $106.87K |
| Michael Heltzen | Chief Executive Officer | 14,203 | $53.26K |
| Fouad Nawaz | Vice President- Finance | 9,488 | $35.58K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the EXOZ quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.